Weibo Corp (WB) Stock Price Today
Aura AI Summary
Key Stats
- $1.80BMARKET_CAP
- -VOLUME
- MediaSECTOR
- $12.83FIFTY_TWO_WEEK_HIGH
- $7.20FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $1.07BENTERPRISE_VALUE
- 8.28%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Weibo Corp (WB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Weibo Corp has traded between a low of $7.2 and a high of $12.83, highlighting its annual price range. Buy and sell Weibo Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Most Recent News
Global infant heart monitor market to reach $7.93B by 2035 with 10.85% CAGR, driven by tech advances and home care demand
The global infant heart monitor market, valued at $2.83 billion in 2025, is projected to grow to $7.93 billion by 2035 at a CAGR of 10.85%. Growth is fueled by advances in wearable and wireless monitoring technologies, increased adoption of home care...

Halper Sadeh LLC probes fairness of major company sales for shareholders' benefit.
Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...

Europe approves TEPKINLY combo for relapsed follicular lymphoma, offering a chemo-free treatment option.
The European Commission has approved TEPKINLY (epcoritamab) combined with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma in adults. This marks the first bispecific antibody-based therapy authorized in Europe for se...
